Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immunomodulating thalidomide analogues patented by Gruenenthal

Oct. 14, 1998

Ono's new PGE2 derivatives show binding affinity for EP2 receptors

Oct. 13, 1998

Development status updated for 3M's imiquimod analogue R-848

Oct. 7, 1998

La Jolla enrolls patients in phase II/III trial for lupus treatment

Oct. 6, 1998

Ono discloses compounds with high binding affinity for prostanoid EP4 receptors

Oct. 6, 1998

Chiroscience identifies new target for autoimmune disease therapy

Oct. 5, 1998

Merck describes new ascomycin derivatives with improved therapeutic potential

Oct. 5, 1998

3M presents first clinical results for potent new immunomodulator

Oct. 5, 1998

Major pediatric study supports safety and efficacy of pneumococcal vaccine

Oct. 1, 1998

Aviron presents new clinical data for FluMist at ICAAC

Oct. 1, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...